![]() |
|
|
Vol. 294, Issue 1, 147-154, July 2000
Department of Pharmacology, College of Medicine, East Tennessee
State University, Johnson City, Tennessee (Y.C., D.B.H., J.C.H.); and
Department of Anatomy and Neurobiology, Faculty of Medicine, Dalhousie
University, Halifax, Nova Scotia, Canada (F.M.S.)
Selective tachykinin agonists were used to identify cardiac and
coronary responses mediated by specific tachykinin receptor subtypes in
isolated, perfused guinea pig hearts. Receptor desensitization with
selective agonists and blockade with selective antagonists were used to
determine the role of specific subtypes in generating responses to
neurokinin A (NKA). Dose-dependent cardiac and coronary effects were
evoked by bolus injections of
[Sar9,Met(O2)11]substance P
([Sar9,Met(O2)11]SP), GR64349,
and [MePhe7]neurokinin B ([MePhe7]NKB)
(selective agonists for NK1, NK2, and
NK3 receptors, respectively). Each agonist caused
bradycardia, but GR64349 was most effective (34 ± 4% decrease in
heart rate with 32 nmol, n = 8). Prominent increases in ventricular contractility and perfusion pressure also
occurred with 32 nmol of GR64349 (25 ± 6 and 33 ± 4%,
respectively). [Sar9,Met(O2)11]SP
was unique in having a high potency for decreasing ventricular contractility and perfusion pressure. Bolus injections of 25 nmol of
NKA decreased rate (48 ± 2%, n = 51),
increased contractility (26 ± 2%), and had biphasic effects on
perfusion pressure (24 ± 1% decrease followed by 9.2 ± 1.4% increase). Desensitization with GR64349 or treatment with the
NK2 antagonist SR48968 reduced the bradycardic response to
NKA by greater than 75% and eliminated the positive inotropic
response. The remaining bradycardia occurred through NK3
receptors. Desensitization with
[Sar9,Met(O2)11]SP or
NK1 blockade with FK888 eliminated the coronary relaxant action of NKA and enhanced the pressor response. It is concluded that
three tachykinin receptor subtypes are present in the guinea pig heart
and that each contributes to the overall response evoked by NKA.
This article has been cited by other articles:
![]() |
A. Sexton, M. McDonald, C. Cayla, C. Thiemermann, and A. Ahluwalia 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1 FASEB J, September 1, 2007; 21(11): 2695 - 2703. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brownbill, N. J. Bell, R. J. Woods, P. J. Lowry, N. M. Page, and C. P. Sibley Neurokinin B Is a Paracrine Vasodilator in the Human Fetal Placental Circulation J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2164 - 2170. [Abstract] [Full Text] [PDF] |
||||